MedPath

Molecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA Profiling

Not yet recruiting
Conditions
Heart Failure
Heart Failure (for Example, Fluid Overload)
Registration Number
NCT07158086
Lead Sponsor
University of Zurich
Brief Summary

The main objective of the study is to achieve a comprehensive phenotyping of patients with heart failure, combining detailed clinical characterization with in-depth molecular profiling. By integrating clinical data with cutting-edge multi-omics techniques (including transcriptomics, epigenomics, and proteomics), this research aims to identify molecular signatures, particularly non-coding RNAs (ncRNAs), that are linked to the onset and progression of HF. Through advanced molecular profiling of biological samples and the analysis of clinical parameters, including advanced imaging, hemodynamic profiling, and biomarker analysis, the study will contribute to the deep phenotyping of HF patients.

The secondary objective aims to uncover potential biomarkers that may serve as predictive indicators of disease progression and identify novel therapeutic targets, offering promising avenues for future treatments in this challenging patient population.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Death from any causeFrom enrollment up to five years
Heart failure hospitalizationFrom enrollment up to five years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Zurich

🇨🇭

Zurich, Switzerland

University Hospital of Zurich
🇨🇭Zurich, Switzerland
Jan A Kleeberger, MD
Principal Investigator
Ludovica Di Venanzio, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.